$12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute's Quest for Improved Targeted Therapies for Melanoma
October 17, 2019
October 17, 2019
PHILADELPHIA, Pennsylvania, Oct. 17 -- The Wistar Institute issued the following news release:
The Wistar Institute and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and development of resistance.
The grant, totaling $12.5 million over five years, is a collaborative, multidisciplinar . . .
The Wistar Institute and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and development of resistance.
The grant, totaling $12.5 million over five years, is a collaborative, multidisciplinar . . .